litlas
ログインアカウント作成

Stephen M. Ansell

1999–2025 年に発表

別表記
Stephen M Ansell
286
論文数
43,714
被引用数
113
h 指数
272
i10 指数

被引用数

Stephen M. Ansell の年別被引用数1987 年: 被引用 1 件1999 年: 被引用 1 件2000 年: 被引用 6 件2001 年: 被引用 8 件2002 年: 被引用 17 件2003 年: 被引用 25 件2004 年: 被引用 51 件2005 年: 被引用 61 件2006 年: 被引用 120 件2007 年: 被引用 123 件2008 年: 被引用 122 件2009 年: 被引用 115 件2010 年: 被引用 179 件2011 年: 被引用 169 件2012 年: 被引用 214 件2013 年: 被引用 245 件2014 年: 被引用 263 件2015 年: 被引用 426 件2016 年: 被引用 411 件2017 年: 被引用 518 件2018 年: 被引用 488 件2019 年: 被引用 1,554 件2020 年: 被引用 1,787 件2021 年: 被引用 1,713 件2022 年: 被引用 1,289 件2023 年: 被引用 1,059 件2024 年: 被引用 1,701 件2025 年: 被引用 670 件2026 年: 被引用 7 件1988〜1998 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,399 件、この内訳の 27.8%中国: 引用元論文 1,594 件、この内訳の 10.1%ドイツ: 引用元論文 919 件、この内訳の 5.8%イタリア: 引用元論文 893 件、この内訳の 5.6%イギリス: 引用元論文 869 件、この内訳の 5.5%フランス: 引用元論文 847 件、この内訳の 5.4%カナダ: 引用元論文 557 件、この内訳の 3.5%スペイン: 引用元論文 557 件、この内訳の 3.5%日本: 引用元論文 472 件、この内訳の 3%オランダ: 引用元論文 428 件、この内訳の 2.7%オーストラリア: 引用元論文 417 件、この内訳の 2.6%スイス: 引用元論文 417 件、この内訳の 2.6%
0%27.8%その他 21.9%

機関

分野

  • Medicine73.2%
  • Biochemistry, Genetics and Molecular Biology14.4%
  • Immunology and Microbiology10.6%
  • Engineering0.3%
  • Computer Science0.3%
  • Neuroscience0.2%
  • その他1%

トピック

  • Lymphoma Diagnosis and Treatment10.8%
  • Cancer Immunotherapy and Biomarkers8.2%
  • CAR-T cell therapy research7.5%
  • Immune Cell Function and Interaction5.4%
  • Chronic Lymphocytic Leukemia Research4.1%
  • Immunotherapy and Immune Responses3.5%
  • その他60.5%

共著者

全論文

検索で開く
  1. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

    著者: Elı́as Campo, Elaine S. Jaffe, James R. Cook, Leticia Quintanilla‐Martínez, Steven H. Swerdlow, Kenneth C. Anderson, Pierre Brousset, Lorenzo Cerroni, Laurence de Leval, Stefan Dirnhofer, Ahmet Doǧan, Andrew L. Feldman, Falko Fend, Jonathan W. Friedberg, Philippe Gaulard, Paolo Ghia, Steven M. Horwitz, Rebecca L. King, Gilles Salles, Jesús F. San Miguel, John F. Seymour, Steven P. Treon, Julie M. Vose, Emanuele Zucca, Ranjana H. Advani, Stephen M. Ansell, Wing-Yan Au, Carlos Barrionuevo, Leif Bergsagel, Wing C. Chan, Jeffrey I. Cohen, Francesco d’Amore, Andrew Davies, Brunangelo Falini, Irene M. Ghobrial, John R. Goodlad, John G. Gribben, Eric D. Hsi, Brad S. Kahl, Won-Seog Kim, Shaji Kumar, Ann S. LaCasce, Camille Laurent, Georg Lenz, John P. Leonard, Michael P. Link, Armando López‐Guillermo, María‐Victoria Mateos, Elizabeth Macintyre, Ari Melnick, Franck Morschhauser, Shigeo Nakamura, Marina Narbaitz, Astrid Pavlovsky, Stefano Pileri, Miguel Á. Piris, Barbara Pro, S. Vincent Rajkumar, Steven T. Rosen, Birgitta Sander, Laurie H. Sehn, Margaret A. Shipp, Sonali M. Smith, Louis M. Staudt, Catherine Thieblemont, Thomas Tousseyn, Wyndham H. Wilson, Tadashi Yoshino, Pier Luigi Zinzani, Martin Dreyling, David W. Scott, Jane N. Winter, Andrew D. Zelenetz - Blood 2022 被引用: 1,506

  2. PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

    著者: Stephen M. Ansell, Alexander M. Lesokhin, Ivan Borrello, Ahmad Halwani, Emma C. Scott, Martin Gutierrez, Stephen J. Schuster, Michael Millenson, Deepika Cattry, Gordon J. Freeman, Scott J. Rodig, Bjoern Chapuy, Azra H. Ligon, Lili Zhu, Joseph F. Grosso, Su Young Kim, John M. Timmerman, Margaret A. Shipp, Philippe Armand - New England Journal of Medicine 2014 被引用: 3,547

  3. Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials

    著者: Yucai Wang, Shouhao Zhou, Fang Yang, Xinyue Qi, Xin Wang, Xiaoxiang Guan, Chan Shen, Narjust Duma, Jesus Vera Aguilera, Ashish V. Chintakuntlawar, Katharine A. Price, Julian R. Molina, Lance C. Pagliaro, Þorvarður R. Hálfdánarson, Axel Grothey, Svetomir N. Markovic, Grzegorz S. Nowakowski, Stephen M. Ansell, Michael Wang - JAMA Oncology 2019 被引用: 846

  4. Odronextamab, a human CD20×CD3 bispecific antibody in patients with CD20-positive B-cell malignancies (ELM-1): results from the relapsed or refractory non-Hodgkin lymphoma cohort in a single-arm, multicentre, phase 1 trial

    著者: Rajat Bannerji, Jon E Arnason, Ranjana H Advani, Jennifer R Brown, John N Allan, Stephen M Ansell, Jeffrey A Barnes, Susan M O'Brien, Julio C Chávez, Johannes Duell, Andreas Rosenwald, Jennifer L Crombie, Melanie Ufkin, Jingjin Li, Min Zhu, Srikanth R Ambati, Aafia Chaudhry, Israel Lowy, Max S Topp - The Lancet Haematology 2022 被引用: 237

  5. Overall Survival with Brentuximab Vedotin in Stage III or IV Hodgkin’s Lymphoma

    著者: Stephen M. Ansell, John Radford, Joseph M. Connors, Monika Długosz‐Danecka, Won-Seog Kim, Andrea Gallamini, Radhakrishnan Ramchandren, Jonathan W. Friedberg, Ranjana H. Advani, Martin Hutchings, Andrew M. Evens, Piotr Smolewski, Kerry J. Savage, Nancy L. Bartlett, Hyeon‐Seok Eom, Jeremy S. Abramson, Cassie Dong, Frank Campana, Keenan Fenton, Markus Puhlmann, David J. Straus - New England Journal of Medicine 2022 被引用: 328

  6. Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies

    著者: Stephen M. Ansell, Michael B. Maris, Alexander M. Lesokhin, Robert W. Chen, Ian W. Flinn, Ahmed Sawas, Mark D. Minden, Diego Villa, Mary‐Elizabeth M. Percival, Anjali S. Advani, James M. Foran, Steven M. Horwitz, Matthew Mei, Jasmine Zain, Kerry J. Savage, Christiane Querfeld, Oleg E. Akilov, Lisa D. Johnson, Tina Catalano, Penka S. Petrova, Robert A. Uger, Eric L. Sievers, Anca Milea, Kathleen Roberge, Yaping Shou, Owen A. O’Connor - Clinical Cancer Research 2021 被引用: 196

  7. Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma

    著者: Joseph M. Connors, Wojciech Jurczak, David J. Straus, Stephen M. Ansell, Won S. Kim, Andrea Gallamini, Anas Younes, Sergey Alekseev, Árpád Illés, Marco Picardi, Ewa Lech‐Marańda, Yasuhiro Oki, Tatyana Feldman, Piotr Smolewski, Kerry J. Savage, Nancy L. Bartlett, Jan Walewski, Robert Chen, Radhakrishnan Ramchandren, Pier Luigi Zinzani, David Cunningham, András Rosta, Neil C. Josephson, Eric Song, Jessica Sachs, Rachael Liu, Hina Jolin, Dirk Huebner, John Radford - New England Journal of Medicine 2017 被引用: 764

  8. Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial

    著者: Philippe Armand, Andreas Engert, Anas Younes, Michelle A. Fanale, Armando Santoro, Pier Luigi Zinzani, John M. Timmerman, Graham P. Collins, Radhakrishnan Ramchandren, Jonathon B. Cohen, Jan Paul de Boer, John Kuruvilla, Kerry J. Savage, Marek Trněný, Margaret A. Shipp, Kazunobu Kato, Anne Sumbul, Benedetto Farsaci, Stephen M. Ansell - Journal of Clinical Oncology 2018 被引用: 754

  9. Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma

    著者: Anas Younes, Ajay K. Gopal, Scott E. Smith, Stephen M. Ansell, Joseph D. Rosenblatt, Kerry J. Savage, Radhakrishnan Ramchandren, Nancy L. Bartlett, Bruce D. Cheson, Sven de Vos, Andres Forero‐Torres, Craig H. Moskowitz, Joseph M. Connors, Andreas Engert, Emily K. Larsen, Dana A. Kennedy, Eric L. Sievers, Robert Chen - Journal of Clinical Oncology 2012 被引用: 1,520

  10. Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study

    著者: Alexander M. Lesokhin, Stephen M. Ansell, Philippe Armand, Emma Scott, Ahmad Halwani, Martin Gutierrez, Michael Millenson, Adam D. Cohen, Stephen J. Schuster, Daniel Lebovic, Madhav V. Dhodapkar, David Avigan, Bjoern Chapuy, Azra H. Ligon, Gordon J. Freeman, Scott J. Rodig, Deepika Cattry, Lili Zhu, Joseph F. Grosso, M. Brigid Garelik, Margaret A. Shipp, Ivan Borrello, John M. Timmerman - Journal of Clinical Oncology 2016 被引用: 1,011

  11. Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma

    著者: Margaretha G.M. Roemer, Robert Redd, Fathima Zumla Cader, Christine J. Pak, Sara Abdelrahman, Jing Ouyang, Stephanie Sasse, Anas Younes, Michelle A. Fanale, Armando Santoro, Pier Luigi Zinzani, John M. Timmerman, Graham P. Collins, Radhakrishnan Ramchandren, Jonathon B. Cohen, Jan Paul de Boer, John Kuruvilla, Kerry J. Savage, Marek Trněný, Stephen M. Ansell, Kazunobu Kato, Benedetto Farsaci, Anne Sumbul, Philippe Armand, Donna Neuberg, Geraldine S. Pinkus, Azra H. Ligon, Scott J. Rodig, Margaret A. Shipp - Journal of Clinical Oncology 2018 被引用: 367

  12. Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL

    著者: Wei Ding, Betsy LaPlant, Timothy G. Call, Sameer A. Parikh, José F. Leis, Rong He, Tait D. Shanafelt, Sutapa Sinha, Jennifer Le‐Rademacher, Andrew L. Feldman, Thomas M. Habermann, Thomas E. Witzig, Gregory A. Wiseman, Yi Lin, Erik Asmus, Grzegorz S. Nowakowski, Michael Conte, Deborah A. Bowen, Casey N. Aitken, Daniel L. Van Dyke, Patricia T. Greipp, Xin Liu, Xiaosheng Wu, Henan Zhang, Charla Secreto, Shulan Tian, Esteban Braggio, Linda Wellik, Ivana N. Micallef, David S. Viswanatha, Huihuang Yan, Asher Chanan‐Khan, Neil E. Kay, Haidong Dong, Stephen M. Ansell - Blood 2017 被引用: 412

  13. Genomic profiling for clinical decision making in lymphoid neoplasms

    著者: Laurence de Leval, Ash A. Alizadeh, P. Leif Bergsagel, Elı́as Campo, Andrew Davies, Ahmet Doǧan, Jude Fitzgibbon, Steven M. Horwitz, Ari Melnick, William G. Morice, Ryan D. Morin, Bertrand Nadel, Stefano Pileri, Richard Rosenquist, Davide Rossi, Itziar Salaverría, Christian Steidl, Steven P. Treon, Andrew D. Zelenetz, Ranjana H. Advani, Carl E. Allen, Stephen M. Ansell, Wing C. Chan, James R. Cook, Lucy Cook, Francesco d’Amore, Stefan Dirnhofer, Martin Dreyling, Kieron Dunleavy, Andrew L. Feldman, Falko Fend, Philippe Gaulard, Paolo Ghia, John G. Gribben, Olivier Hermine, Daniel J. Hodson, Eric D. Hsi, Giorgio Inghirami, Elaine S. Jaffe, Kennosuke Karube, Keisuke Kataoka, Wolfgang Hiddemann, Won Seog Kim, Rebecca L. King, Young Hyeh Ko, Ann S. LaCasce, Georg Lenz, José I. Martín‐Subero, Miguel Á. Piris, Stefania Pittaluga, Laura Pasqualucci, Leticia Quintanilla‐Martínez, Scott J. Rodig, Andreas Rosenwald, Gilles Salles, Jesús F. San Miguel, Kerry J. Savage, Laurie H. Sehn, Gianpietro Semenzato, Louis M. Staudt, Steven H. Swerdlow, Constantine S. Tam, Judith Trotman, Julie M. Vose, Oliver Weigert, Wyndham H. Wilson, Jane N. Winter, Catherine J. Wu, Pier Luigi Zinzani, Emanuele Zucca, Adam Bagg, David W. Scott - Blood 2022 被引用: 161

  14. Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy

    著者: Bruce D. Cheson, Stephen M. Ansell, Larry Schwartz, Leo I. Gordon, Ranjana H. Advani, Heather A. Jacene, Axel Hoos, Sally F. Barrington, Philippe Armand - Blood 2016 被引用: 506

  15. Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study

    著者: Stephen M. Ansell, Monique C. Minnema, Peter Johnson, John M. Timmerman, Philippe Armand, Margaret A. Shipp, Scott J. Rodig, Azra H. Ligon, Margaretha G.M. Roemer, Nishitha Reddy, Jonathon B. Cohen, Sarit Assouline, Michelle Poon, Manish Sharma, Kazunobu Kato, Selda Samakoglu, Anne Sumbul, Andrew Grigg - Journal of Clinical Oncology 2019 被引用: 363

  16. Brentuximab vedotin in combination with nivolumab in relapsed or refractory Hodgkin lymphoma: 3-year study results

    著者: Ranjana H. Advani, Alison J. Moskowitz, Nancy L. Bartlett, Julie M. Vose, Radhakrishnan Ramchandren, Tatyana Feldman, Ann S. LaCasce, Beth Christian, Stephen M. Ansell, Craig H. Moskowitz, Lisa Brown, Chiyu Zhang, David R. Taft, Sahar Ansari, Mariana Sacchi, Linda Ho, Alex F. Herrera - Blood 2021 被引用: 218

  17. A phase 1b study of AFM13 in combination with pembrolizumab in patients with relapsed or refractory Hodgkin lymphoma

    著者: Nancy L. Bartlett, Alex F. Herrera, Eva Domingo‐Doménech, Amitkumar Mehta, Andres Forero‐Torres, Ramón García‐Sánz, Philippe Armand, Sumana Devata, Antonia Rodríguez Izquierdo, Izidore S. Lossos, Craig B. Reeder, Taimur Sher, Robert Chen, Sylvia E. Schwarz, Leila Alland, András Strassz, Kim Prier, Cassandra Choe-Juliak, Stephen M. Ansell - Blood 2020 被引用: 151

  18. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing

    著者: Jens G. Lohr, Petar Stojanov, Michael S. Lawrence, Daniel Auclair, Bjoern Chapuy, Carrie Sougnez, Peter Cruz‐Gordillo, Birgit Knoechel, Yan W. Asmann, Susan L. Slager, Anne J. Novak, Ahmet Doǧan, Stephen M. Ansell, Brian K. Link, Lihua Zou, Joshua Gould, Gordon Saksena, Nicolas Stransky, Claudia Rangel‐Escareño, Juan Carlos Fernández-López, Alfredo Hidalgo‐Miranda, Jorge Meléndez-Zajgla, Enrique Hernández–Lemus, Angela Schwarz‐Cruz y Celis, Iván Imaz-Rosshandler, Akinyemi I. Ojesina, Joonil Jung, Chandra Sekhar Pedamallu, Eric S. Lander, Thomas M. Habermann, James R. Cerhan, Margaret A. Shipp, Gad Getz, Todd R. Golub - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 被引用: 980

  19. Nivolumab for classical Hodgkin's lymphoma after failure of both autologous stem-cell transplantation and brentuximab vedotin: a multicentre, multicohort, single-arm phase 2 trial

    著者: Anas Younes, Armando Santoro, Margaret A. Shipp, Pier Luigi Zinzani, John M. Timmerman, Stephen M. Ansell, Philippe Armand, Michelle A. Fanale, Voravit Ratanatharathorn, John Kuruvilla, Jonathon B. Cohen, Graham P. Collins, Kerry J. Savage, Marek Trněný, Kazunobu Kato, Benedetto Farsaci, Susan Parker, Scott J. Rodig, Margaretha G.M. Roemer, Azra H. Ligon, Andreas Engert - The Lancet Oncology 2016 被引用: 924

  20. Nivolumab for Newly Diagnosed Advanced-Stage Classic Hodgkin Lymphoma: Safety and Efficacy in the Phase II CheckMate 205 Study

    著者: Radhakrishnan Ramchandren, Eva Domingo‐Doménech, Antonio Rueda, Marek Trněný, Tatyana Feldman, Hun Ju Lee, Mariano Provencio, Christian Sillaber, Jonathon B. Cohen, Kerry J. Savage, Wolfgang Willenbacher, Azra H. Ligon, Jing Ouyang, Robert Redd, Scott J. Rodig, Margaret A. Shipp, Mariana Sacchi, Anne Sumbul, Philippe Armand, Stephen M. Ansell - Journal of Clinical Oncology 2019 被引用: 256

  21. Expression of LAG-3 defines exhaustion of intratumoral PD-1+ T cells and correlates with poor outcome in follicular lymphoma

    著者: Zhi‐Zhang Yang, Hyo Jin Kim, José C. Villasboas, Yaping Chen, Tammy Price-Troska, Shahrzad Jalali, Mara Wilson, Anne J. Novak, Stephen M. Ansell - Oncotarget 2017 被引用: 219

  22. T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

    著者: Steven M. Horwitz, Stephen M. Ansell, Weiyun Z. Ai, Jeffrey A. Barnes, Stefan K. Barta, Jonathan E. Brammer, Mark W. Clemens, Ahmet Doǧan, Francine M. Foss, Paola Ghione, Aaron M. Goodman, Joan Guitart, Ahmad Halwani, Bradley M. Haverkos, Richard T. Hoppe, Eric D. Jacobsen, Deepa Jagadeesh, Allison Jones, Avyakta Kallam, Youn H. Kim, Kiran A. Kumar, Neha Mehta–Shah, Elise A. Olsen, Saurabh Rajguru, Sima Rozati, Jonathan Said, Aaron C. Shaver, Lauren Shea, Michi M. Shinohara, Lubomir Sokol, Carlos A. Torres‐Cabala, Ryan A. Wilcox, Peggy A. Wu, Jasmine Zain, Mary A. Dwyer, Hema Sundar - Journal of the National Comprehensive Cancer Network 2022 被引用: 167

  23. Use of Chimeric Antigen Receptor T Cell Therapy in Clinical Practice for Relapsed/Refractory Aggressive B Cell Non-Hodgkin Lymphoma: An Expert Panel Opinion from the American Society for Transplantation and Cellular Therapy

    著者: Tania Jain, Merav Bar, Ankit Kansagra, Elise A. Chong, Shahrukh K. Hashmi, Sattva S. Neelapu, Michael Byrne, Elad Jacoby, Aleksandr Lazaryan, Caron A. Jacobson, Stephen M. Ansell, Farrukh T. Awan, Linda J. Burns, Veronika Bachanová, Catherine M. Bollard, Paul A. Carpenter, John F. DiPersio, Mehdi Hamadani, Helen E. Heslop, Joshua A. Hill, Krishna V. Komanduri, Craig A. Kovitz, Hillard M. Lazarus, Justin M. Serrette, Mohamad Mohty, David B. Miklos, Arnon Nagler, Steven Z. Pavletic, Bipin N. Savani, Stephen J. Schuster, Mohamed A. Kharfan‐Dabaja, Miguel‐Angel Perales, Yi Lin - Biology of Blood and Marrow Transplantation 2019 被引用: 192

  24. TIGIT Expression Is Associated with T-cell Suppression and Exhaustion and Predicts Clinical Outcome and Anti–PD-1 Response in Follicular Lymphoma

    著者: Zhi‐Zhang Yang, Hyo Jin Kim, Hongyan Wu, Shahrzad Jalali, Xinyi Tang, Jordan E. Krull, Wei Ding, Anne J. Novak, Stephen M. Ansell - Clinical Cancer Research 2020 被引用: 115